Skip to main
BLND

Blend Labs (BLND) Stock Forecast & Price Target

Blend Labs (BLND) Analyst Ratings

Based on 7 analyst ratings
Buy
Strong Buy 29%
Buy 43%
Hold 29%
Sell 0%
Strong Sell 0%

Bulls say

Blend Labs Inc demonstrates a strong financial outlook with a robust pipeline that has grown 18% year-over-year, capturing over 4% of the 2024 HMDA market share. The introduction of the Rapid Refi product is expected to enhance profitability by increasing the average economic value per loan, illustrating the company’s commitment to innovation in a challenging mortgage environment. Furthermore, strong performance in the consumer banking suite, evidenced by a 43% increase in revenue, showcases Blend's expanding total addressable market and effective market penetration.

Bears say

Blend Labs Inc. faces a negative outlook primarily due to a larger-than-expected decline in mortgage volumes, which poses a risk to the company’s revenue generation from its key Blend Platform segment. Additionally, the mortgage economic value per funded loan has decreased from $93 to $88, reflecting challenges associated with a transition to a partnership model in its homeowner insurance and income verification businesses. With anticipated interest rate hikes in the coming years and potential further drops in mortgage volume, Blend’s ability to achieve its financial targets may be significantly hampered.

Blend Labs (BLND) has been analyzed by 7 analysts, with a consensus rating of Buy. 29% of analysts recommend a Strong Buy, 43% recommend Buy, 29% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Blend Labs and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Blend Labs (BLND) Forecast

Analysts have given Blend Labs (BLND) a Buy based on their latest research and market trends.

According to 7 analysts, Blend Labs (BLND) has a Buy consensus rating as of Dec 24, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $5.11, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $5.11, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Blend Labs (BLND)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.